Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Plans Should Cover All Drugs During Start-Up, CMS Says

Executive Summary

Medicare Rx plans will be expected to provide new enrollees a one-time prescription for drugs not on formulary to ease the transition into Part D, the Centers for Medicare & Medicaid Services says

You may also be interested in...



CMS Urged To Exempt Mentally Ill From Prior Authorization Under Part D

CMS should require prescription drug plan adherence to consumer-oriented "best practices" rather than allow formulary management tactics that curb benefits for the mentally ill, according to the Medicare Rights Center

CMS Urged To Exempt Mentally Ill From Prior Authorization Under Part D

CMS should require prescription drug plan adherence to consumer-oriented "best practices" rather than allow formulary management tactics that curb benefits for the mentally ill, according to the Medicare Rights Center

Pennsylvania Medicaid Seeks To Coordinate Dual Eligible Care With PDPs

The Pennsylvania Medicaid program is exploring ways to coordinate care of its dual eligible population with Medicare prescription drug plans

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045570

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel